KIRK NICHOLAS PANDELIDIS, M.D.

YORK, PA

Research Active
Orthopaedic Surgery NPI registered 21+ years 1 publication 2013 – 2013 NPI: 1942205893
Orthopaedic Surgery
Anti-Bacterial AgentsMicrobial Sensitivity TestsDrug Resistance, BacterialBronchopulmonary DysplasiaInfant, PrematureBiofilmsUreaplasma InfectionsUreaplasma urealyticum

Practice Location

1855 POWDER MILL RD
YORK, PA 17402-4723

Phone: (717) 848-4800

What does KIRK PANDELIDIS research?

Dr. Pandelidis studies the impact of Ureaplasma, a type of bacteria that can lead to lung problems, especially in preterm infants. He investigates how Ureaplasma forms protective clusters known as biofilms, which can influence how these bacteria respond to antibiotics. Through his work, he aims to enhance the understanding of lung diseases that affect premature babies, particularly bronchopulmonary dysplasia, a serious condition where the lungs are damaged and hinder breathing.

Key findings

  • In a study published in 2013, 95% of Ureaplasma samples from preterm neonates were found to form biofilms.
  • The formation of biofilms did not significantly increase the resistance of Ureaplasma to the antibiotics azithromycin and erythromycin.
  • Understanding Ureaplasma's behavior can improve treatment approaches for lung issues in vulnerable preterm infants.

Frequently asked questions

Does Dr. Pandelidis study lung problems in preterm infants?
Yes, he specializes in researching lung health issues, particularly those caused by Ureaplasma infections in preterm infants.
What role do biofilms play in Ureaplasma infections?
Biofilms are protective clusters formed by Ureaplasma that help the bacteria survive, but Dr. Pandelidis found that they do not significantly increase resistance to certain antibiotics.
What treatments has Dr. Pandelidis researched for preterm infants?
He has researched the effectiveness of antibiotics like azithromycin and erythromycin in treating Ureaplasma infections in preterm infants.

Publications in plain English

Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates.

2013

The Pediatric infectious disease journal

Pandelidis K, McCarthy A, Chesko KL, Viscardi RM

Plain English
This study examined whether bacteria called Ureaplasma, which can cause lung problems in preterm babies, can form protective clusters called biofilms. Researchers found that 95% of Ureaplasma samples from these infants could form biofilms, but forming these biofilms did not make them significantly more resistant to the antibiotics azithromycin and erythromycin. This is important because understanding how Ureaplasma behaves can help doctors treat lung issues in vulnerable preterm infants more effectively. Who this helps: This helps doctors treating preterm infants at risk for lung diseases.

PubMed

Frequent Co-Authors

Amanda McCarthy Kirsty L Chesko Rose M Viscardi

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.